Header Logo

Connection

ANKHI DUTTA to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications ANKHI DUTTA has written about Dose-Response Relationship, Drug.
ANKHI DUTTA
Connection Strength
0.013
Dose-Response Relationship, Drug
  1. Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer. Cancer. 2006 May 15; 106(10):2241-6.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.